Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk

March 16, 2023
The French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts. 

from Health and Science https://ift.tt/JG95WzI
https://ift.tt/Yz92o8U
https://ift.tt/rdXGUIZ

Leave a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.